Raise closed, search for fresh raises on Seedstage

Santa Clarita, CA

Fundraising to scale and distribute therapeutic robotic pets that provide emotional support.

• Mission: Expanding the availability of realistic robotic companion animals to provide emotional support for individuals with conditions like dementia, autism, and other health challenges.  
• Innovation: Tombot’s highly realistic robotic pets, such as the Tombot Puppy, simulate lifelike behaviors to offer calming interactions and positive mental health benefits.  
• Therapeutic Impact: Designed to help alleviate symptoms of dementia and provide companionship, particularly for those unable to care for live animals, fostering emotional attachment and reducing isolation.  
• Market Opportunity: Tombot plans to scale production and partner with healthcare institutions, including memory care centers and hospitals, to reach a broad audience in therapeutic settings.  
• Development Strategy: Funds raised will support product feature enhancements, increased production capacity, and the expansion of distribution channels through both B2B and direct-to-consumer sales.  
• Leadership and Vision: With a focus on leveraging cutting-edge robotics and ongoing research, Tombot aims to be a transformative player in emotional support and therapeutic care for individuals in need.

Tombot is fundraising to expand its development and production of highly realistic robotic companion animals designed to support individuals who may benefit from a therapeutic pet but are unable to care for live animals, such as those with dementia, autism, or other health conditions. These companion robots are crafted to provide emotional support, with lifelike behaviors that promote calming interactions and stimulate positive mental health outcomes by mimicking the appearance and responses of a real pet.

With the funds raised, Tombot aims to scale production, enhance product features, and broaden distribution channels, including partnerships with healthcare institutions like memory care centers, hospitals, and other therapeutic settings. By leveraging cutting-edge robotics and user-focused design, Tombot is committed to becoming a transformative presence in emotional support and therapeutic care, bringing comfort and companionship to individuals in need through accessible and engaging technology.

Company Info

Tombot, Inc. creates realistic robotic pets designed to provide emotional support for individuals with dementia and other mental health conditions.

Tombot, Inc. develops highly realistic robotic animals intended as companion pets for individuals who cannot own live pets, particularly those with dementia and other mental health conditions. The company’s primary product, the Tombot Puppy, is designed to stimulate emotional attachment and alleviate symptoms associated with dementia. Headquartered in California and incorporated in Delaware in 2017, Tombot targets both direct-to-consumer sales through e-commerce and business-to-business sales via a dedicated sales team across healthcare facilities, including memory care and assisted living.

Tombot aims to provide therapeutic benefits to various groups, from cognitively typical seniors experiencing isolation to children with developmental disabilities. Supported by patents and ongoing research, Tombot continues to develop its products with plans for initial shipments in 2025. The company’s product line, while not FDA-approved, has been explored as a wellness tool, potentially expanding into regulated markets in the future.